Akebia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
CEOJohn P. Butler
CEOJohn P. Butler
Employees181
Employees181
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2007
Founded2007
Employees181
Employees181
AKBA Key Statistics
Market cap686.79M
Market cap686.79M
Price-Earnings ratio-12.13
Price-Earnings ratio-12.13
Dividend yield—
Dividend yield—
Average volume4.83M
Average volume4.83M
High today$2.64
High today$2.64
Low today$2.53
Low today$2.53
Open price$2.54
Open price$2.54
Volume3.59M
Volume3.59M
52 Week high$2.90
52 Week high$2.90
52 Week low$0.80
52 Week low$0.80
AKBA News
Simply Wall St 7d
Akebia Therapeutics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextInvestors in Akebia Therapeutics, Inc. ( ) had a good week, as its shares rose 4.1% to close at US$2.55 following the release of its first-quarter results. In a...
People also own
Based on the portfolios of people who own AKBA. This list is generated using Robinhood data, and it’s not a recommendation.